phase ii piovt-hd trial of ptc518 in early huntington's disease
Published 1 year ago • 961 plays • Length 3:35Download video MP4
Download video MP3
Similar videos
-
39:50
hdsa research webinar: update from ptc therapeutics on the pivot-hd trial
-
5:08
ptc518: oral splicing modifier under investigation for the treatment of huntington’s disease
-
55:26
webinar | on the 'ptc518' clinical trial updates
-
1:16:30
clinical trial showcase | 37th annual #hdsaconvention
-
5:38
proof-hd: phase iii trial of oral s1r agonist pridopidine for the treatment of huntington’s disease
-
58:15
an update on hd clinical trials in canada
-
51:15
webinar: updates on the select hd clinical trial on huntington's disease
-
1:00:40
hdsa research webinar: hd clinical trial update
-
48:25
what clinical trials taught us and how hd therapeutic development is accelerating in 2022
-
46:23
clear-hd clinical trial | huntington's disease webinar
-
9:01
vibrant hd - novartis clinical trial for huntington's disease
-
49:46
clinical trials in premanifest hd review of prequel results and prospects for the future
-
5:51
first-hd overview - a huntington disease clinical trial
-
38:31
research webinar: pride hd clinical trial results
-
1:58
proof-hd huntington disease trial is fully recruited and ahead of schedule
-
3:32
kinect-hd: about clinical trials
-
1:04:45
38th annual hdsa convention clinical trials showcase
-
46:57
enroll-hd | huntington's disease webinar
-
49:21
webinar: phase 2 generation hd2 clinical trial is open now